Return to Clinical Trials Search Results

Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy for pT3/T4 Urothelial Bladder Cancer

Primary Objective: To evaluate the ability of post-cystectomy adjuvant radiotherapy to safely reduce pelvic tumor recurrence, defined as pelvic recurrence-free survival in Section 16.3.2. Secondary Objectives: Evaluate increase in disease-free survival Evaluate toxicity of adjuvant pelvic radiotherapy



Recruitment Status

Past Studies